Malawi-Liverpool-Wellcome Programme, Blantyre, Malawi.
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
BMC Med. 2024 Sep 27;22(1):419. doi: 10.1186/s12916-024-03631-5.
Adults living with human immunodeficiency virus (ALWHIV) receiving antiretroviral therapy (ART) exhibit higher pneumococcal carriage prevalence than adults without HIV (HIV-). To assess factors influencing high pneumococcal carriage in ALWHIV, we estimated pneumococcal carriage acquisition and clearance rates in a high transmission and disease-burdened setting at least 10 years after introducing infant PCV13 in routine immunisation.
We collected longitudinal nasopharyngeal swabs from individuals aged 18-45 in Blantyre, Malawi. The study group included both HIV- individuals and those living with HIV, categorised based on ART duration as either exceeding 1 year (ART > 1y) or less than 3 months (ART < 3 m). Samples were collected at baseline and then weekly for 16 visits. To detect pneumococcal carriage, we used classical culture microbiology, and to determine pneumococcal serotypes, we used latex agglutination. We modelled trajectories of serotype colonisation using multi-state Markov models to capture pneumococcal carriage dynamics, adjusting for age, sex, number of under 5 year old (< 5y) children, social economic status (SES), and seasonality.
We enrolled 195 adults, 65 adults in each of the study groups. 51.8% were females, 25.6% lived with more than one child under 5 years old, and 41.6% lived in low socioeconomic areas. The median age was 33 years (IQR 25-37 years). The baseline pneumococcal carriage prevalence of all serotypes was 31.3%, with non-PCV13 serotypes (NVT) at 26.2% and PCV13 serotypes (VT) at 5.1%. In a multivariate longitudinal analysis, pneumococcal carriage acquisition was higher in females than males (hazard ratio [HR], NVT [1.53]; VT [1.96]). It was also higher in low than high SES (NVT [1.38]; VT [2.06]), in adults living with 2 + than 1 child < 5y (VT [1.78]), and in ALWHIV on ART > 1y than HIV- adults (NVT [1.43]). Moreover, ALWHIV on ART > 1y cleared pneumococci slower than HIV- adults ([0.65]). Residual VT 19F and 3 were highly acquired, although NVT remained dominant.
The disproportionately high point prevalence of pneumococcal carriage in ALWHIV on ART > 1y is likely due to impaired nasopharyngeal clearance, which results in prolonged carriage. Our findings provide baseline estimates for comparing pneumococcal carriage dynamics after implementing new PCV strategies in ALWHIV.
接受抗逆转录病毒疗法(ART)的成人艾滋病毒感染者(ALWHIV)比没有艾滋病毒的成年人(HIV-)表现出更高的肺炎球菌携带率。为了评估影响 ALWHIV 中高肺炎球菌携带率的因素,我们在引入婴儿 PCV13 常规免疫接种至少 10 年后,在高传播和疾病负担地区评估了肺炎球菌携带的获得和清除率。
我们从马拉维布兰太尔 18-45 岁的个体中收集了纵向鼻咽拭子。研究组包括 HIV-个体和那些感染 HIV 的个体,根据 ART 持续时间分为超过 1 年(ART>1y)或不到 3 个月(ART<3m)。基线时采集样本,然后每周采集 16 次。为了检测肺炎球菌携带,我们使用经典的培养微生物学方法,为了确定肺炎球菌血清型,我们使用乳胶凝集法。我们使用多状态马尔可夫模型来模拟血清型定植的轨迹,以捕捉肺炎球菌携带的动态,调整年龄、性别、5 岁以下儿童(<5y)数量、社会经济地位(SES)和季节性。
我们共纳入 195 名成年人,每组 65 名成年人。51.8%为女性,25.6%与 2 个以上 5 岁以下儿童同住,41.6%居住在低社会经济地区。中位年龄为 33 岁(IQR 25-37 岁)。所有血清型的基线肺炎球菌携带率为 31.3%,非 PCV13 血清型(NVT)为 26.2%,PCV13 血清型(VT)为 5.1%。在多变量纵向分析中,女性比男性更容易获得肺炎球菌(危险比[HR],NVT[1.53];VT[1.96])。在低 SES 地区比高 SES 地区更容易获得肺炎球菌(NVT[1.38];VT[2.06]),与 1 个 5 岁以下儿童相比,与 2 个以上儿童同住(VT[1.78]),以及与接受 ART>1y 的 ALWHIV 相比,与 HIV-成年人(NVT[1.43])相比。此外,接受 ART>1y 的 ALWHIV 清除肺炎球菌的速度比 HIV-成年人慢([0.65])。尽管 NVT 仍然占主导地位,但 VT19F 和 3 型的获得率仍然很高。
接受 ART>1y 的 ALWHIV 中肺炎球菌携带率的不成比例高可能是由于鼻咽清除功能受损导致的,这导致携带时间延长。我们的研究结果为在 ALWHIV 中实施新的 PCV 策略后比较肺炎球菌携带动力学提供了基线估计。